P.M. Wencyk

1.1k total citations
15 papers, 909 citations indexed

About

P.M. Wencyk is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, P.M. Wencyk has authored 15 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in P.M. Wencyk's work include HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers) and Breast Lesions and Carcinomas (4 papers). P.M. Wencyk is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Breast Cancer Treatment Studies (4 papers) and Breast Lesions and Carcinomas (4 papers). P.M. Wencyk collaborates with scholars based in United Kingdom. P.M. Wencyk's co-authors include Ian O. Ellis, JA Bell, Robert I. Nicholson, Joshua A. Bell, CW Elston, Sarah E. Pinder, R.W. Blamey, RW Blamey, JFR Robertson and S Pinder and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

P.M. Wencyk

15 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P.M. Wencyk United Kingdom	12	582	371	321	215	187	15	909
Yoshiatsu Sagara Japan	14	484 0.8×	246 0.7×	337 1.0×	92 0.4×	156 0.8×	26	804
Yasuyo Ohi Japan	21	635 1.1×	314 0.8×	474 1.5×	142 0.7×	195 1.0×	60	1.2k
CW Elston United Kingdom	12	921 1.6×	382 1.0×	680 2.1×	288 1.3×	333 1.8×	12	1.4k
Narinder Tamber United Kingdom	13	459 0.8×	533 1.4×	456 1.4×	202 0.9×	197 1.1×	13	1.1k
Frank Mross Switzerland	3	515 0.9×	521 1.4×	362 1.1×	79 0.4×	153 0.8×	7	1.0k
JM Varley United Kingdom	9	545 0.9×	426 1.1×	221 0.7×	148 0.7×	94 0.5×	11	814
Shyam M. Kavuri United States	10	751 1.3×	381 1.0×	383 1.2×	245 1.1×	131 0.7×	11	1.1k
Masahiro Watatani Japan	20	429 0.7×	547 1.5×	330 1.0×	108 0.5×	333 1.8×	57	1.2k
Barbara Dunne United Kingdom	12	482 0.8×	536 1.4×	230 0.7×	98 0.5×	147 0.8×	21	973
JFR Robertson United Kingdom	12	435 0.7×	327 0.9×	333 1.0×	66 0.3×	184 1.0×	13	830

Countries citing papers authored by P.M. Wencyk

Since Specialization

Citations

This map shows the geographic impact of P.M. Wencyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.M. Wencyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.M. Wencyk more than expected).

Fields of papers citing papers by P.M. Wencyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.M. Wencyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.M. Wencyk. The network helps show where P.M. Wencyk may publish in the future.

Co-authorship network of co-authors of P.M. Wencyk

This figure shows the co-authorship network connecting the top 25 collaborators of P.M. Wencyk. A scholar is included among the top collaborators of P.M. Wencyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.M. Wencyk. P.M. Wencyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kollias, James, Sarah E. Pinder, Helen Denley, et al.. (2004). Phenotypic similarities in bilateral breast cancer. Breast Cancer Research and Treatment. 85(3). 255–261. 18 indexed citations

Barnes, A., JA Bell, P.M. Wencyk, et al.. (2003). Expression of p27kip1 in breast cancer and its prognostic significance. The Journal of Pathology. 201(3). 451–459. 37 indexed citations

Lambie, Hannah, S Pinder, JA Bell, et al.. (2003). Prognostic significance of BRCA1 expression in sporadic breast carcinomas. The Journal of Pathology. 200(2). 207–213. 48 indexed citations

Dowsett, Mitch, J. M. S. Bartlett, Ian O. Ellis, et al.. (2003). Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres. The Journal of Pathology. 199(4). 418–423. 191 indexed citations

Pinder, Sarah E., A H S Lee, Joshua A. Bell, et al.. (2002). Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 40(3). 215–222. 112 indexed citations

Bell, Joshua A., et al.. (2001). Delay to fixation of invasive breast carcinoma: Effect on mitotic count, MIB1, ER and P53 expression. European Journal of Cancer. 37. 10–10. 3 indexed citations

Rampaul, R.S., S Pinder, P.M. Wencyk, et al.. (2001). Epidermal Growth Factor Receptor (EGFR) expression: Prognostic value in breast cancer patients with long-term follow-up. European Journal of Cancer. 37. 12–12. 1 indexed citations

Parker, Catriona, R.S. Rampaul, Sarah E. Pinder, et al.. (2001). E-cadherin as a prognostic indicator in primary breast cancer. British Journal of Cancer. 85(12). 1958–1963. 67 indexed citations

Dowsett, Mitch, Ian O. Ellis, Janine Salter, et al.. (2001). Correlation between immunohistochemical and fish analysis for HER-2 in 441 breast carcinomas from multiple hospitals. European Journal of Cancer. 37. 3–4. 2 indexed citations

10.

Gonzalez, Michael, Sarah E. Pinder, P.M. Wencyk, et al.. (1999). An immunohistochemical examination of the expression of E-cadherin, ?- and ?/?-catenins, and ?2- and ?1-integrins in invasive breast cancer. The Journal of Pathology. 187(5). 523–529. 84 indexed citations

11.

Pinder, S, C.W. Elston, Joshua A. Bell, et al.. (1997). Intratumoural heterogeneity of proliferation in invasive breast carcinoma evaluated with MIBI antibody. The Breast. 6(4). 171–176. 22 indexed citations

12.

Pinder, S, JA Bell, P.M. Wencyk, et al.. (1996). C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators. British Journal of Cancer. 74(2). 229–233. 106 indexed citations

13.

Pinder, Sarah E., P.M. Wencyk, Joshua A. Bell, et al.. (1995). The assessment of multiple variables on breast carcinoma fine needle aspiration (FNA) cytology specimens: method, preliminary results and prognostic associations. Cytopathology. 6(5). 316–324. 17 indexed citations

14.

Wencyk, P.M., JA Bell, CW Elston, et al.. (1995). Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. British Journal of Cancer. 71(1). 146–149. 156 indexed citations

15.

Watson, S A, et al.. (1991). Intracellular Gastrin in Human Gastrointestinal Tumor Cells. JNCI Journal of the National Cancer Institute. 83(12). 866–871. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact